Abstract:Background: The oncogenic process is orchestrated by a complex network of chromatin remodeling elements that shape the cancer epigenome. Histone variant H2A.Z regulates DNA control elements such as promoters and enhancers in different types of cancer; however, the interplay between H2A.Z and the pancreatic cancer epigenome is unknown. Objective: This study analyzed the role of H2A.Z in different DNA regulatory elements. Methods: We performed Chromatin Immunoprecipitation Sequencing assays (ChiP-seq) with total H2A.Z and acetylated H2A.Z (acH2A.Z) antibodies and analyzed published data from ChIP-seq, RNA-seq, bromouridine labeling-UV and sequencing (BruUV-seq), Hi-C and ATAC-seq (Assay for Transposase-Accessible Chromatin using sequencing) in the pancreatic cancer cell line PANC-1. Results: The results indicate that total H2A.Z facilitates the recruitment of RNA polymerase II and transcription factors at promoters and enhancers allowing the expression of pro-oncogenic genes. Interestingly, we demonstrated that H2A.Z is enriched in super-enhancers (SEs) contributing to the transcriptional activation of key genes implicated in tumor development. Importantly, we established that H2A.Z contributes to the three-dimensional (3D) genome organization of pancreatic cancer and that it is a component of the Topological Associated Domains (TADs) boundaries in PANC-1 and that total H2A.Z and acH2A.Z are associated with A and B compartments, respectively. Conclusions: H2A.Z participates in the biology and development of pancreatic cancer by generating a pro-oncogenic transcriptome through its posttranslational modifications, interactions with different partners, and regulatory elements, contributing to the oncogenic 3D genome organization. These data allow us to understand the molecular mechanisms that promote an oncogenic transcriptome in pancreatic cancer mediated by H2A.Z.

Histone Acetylation Insulator SET Orchestrates PP2A Inhibition and Super-Enhancer Activation

PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells

Cyclin-dependent Kinase 1-Mediated Phosphorylation of SET at Serine 7 is Essential for Its Oncogenic Activity

Interplay Between the Histone Variant H2A.Z and the Epigenome in Pancreatic Cancer

The function of histone methyltransferase SETDB1 and its roles in liver cancer

Phosphorylation of ETS1 by Src Family Kinases Prevents Its Recognition by the COP1 Tumor Suppressor.

Targeting the Tumor Epigenetic Regulator SETDB1 for Tumor Therapy

The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.

DKK1-SE recruits AP1 to activate the target gene DKK1 thereby promoting pancreatic cancer progression

Super-enhancer RNA m 6 A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma

KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.

Targeting the epigenetic reader ENL inhibits super-enhancer-driven oncogenic transcription and synergizes with BET inhibition to suppress tumor progression

Histone Deacetylase 3 Promotes Pancreatic Cancer Cell Proliferation, Invasion And Increases Drug-Resistance Through Histone Modification Of P27, P53 And Bax

Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes

Histone Methyltransferase SETDB1 Regulates Liver Cancer Cell Growth Through Methylation of P53

H3.3K27M Mutant Proteins Reprogram Epigenome by Sequestering the PRC2 Complex to Poised Enhancers

DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer

Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer

Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression

Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex

Involvement of Set in the Wnt Signaling Pathway and the Development of Human Colorectal Cancer